Mulay James
SEC insider (Form 3/4/5 filer). CIK 0001684531. Director at CG Oncology, Inc. (CGON). 32 reported Form 4/5 transactions since Sep 2024; latest on Jul 10, 2026. Located in DALLAS, TX.
Companies Mulay James has filed insider reports for
- CG Oncology, Inc. (CGON): Director
Mulay James
CIK: 0001684531
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CG Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jul 10, 2026CGON
CG Oncology, Inc.
ExerciseDirect24.2K shares at avg. $26.63$644K - Jul 10, 2026CGON
CG Oncology, Inc.
SaleDirect24.2K shares at avg. $75.16$1.8M - Jun 15, 2026CGON
CG Oncology, Inc.
ExerciseDirect1.3K shares at avg. $12.59$16K - Jun 15, 2026CGON
CG Oncology, Inc.
ExerciseDirect654 shares at avg. $3.72$2K - Jun 15, 2026CGON
CG Oncology, Inc.
SaleDirect654 shares at avg. $60.12$39K - Jun 15, 2026CGON
CG Oncology, Inc.
SaleDirect1.3K shares at avg. $60.12$79K - Jun 4, 2026CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
9.4K shares- - Apr 17, 2026CGON
CG Oncology, Inc.
ExerciseDirect15.6K shares at avg. $36.63$571K - Apr 17, 2026CGON
CG Oncology, Inc.
SaleDirect15.6K shares at avg. $73.01$1.1M - Mar 16, 2026CGON
CG Oncology, Inc.
SaleDirect1.3K shares at avg. $63.50$83K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 | CGON CG Oncology, Inc. | Exercise | 24,165 | $26.63 | $643,514 | Direct |
| Jul 10, 2026 | CGON CG Oncology, Inc. | Sale | 24,165 | $75.16 | $1,816,241 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Exercise | 1,310 | $12.59 | $16,493 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Exercise | 654 | $3.72 | $2,433 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Sale | 654 | $60.12 | $39,318 | Direct |
| Jun 15, 2026 | CGON CG Oncology, Inc. | Sale | 1,310 | $60.12 | $78,757 | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Apr 17, 2026 | CGON CG Oncology, Inc. | Exercise | 15,600 | $36.63 | $571,428 | Direct |
| Apr 17, 2026 | CGON CG Oncology, Inc. | Sale | 15,600 | $73.01 | $1,138,956 | Direct |
| Mar 16, 2026 | CGON CG Oncology, Inc. | Sale | 1,310 | $63.50 | $83,185 | Direct |
1-10 of 32 transactions